@article{2dc26c04d4ca427a98186d8dee336598,
title = "Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas",
keywords = "Diffuse large B-cell lymphoma, Direct-acting antivirals, Hepatitis C virus, R-CHOP, antivirus agent, cyclophosphamide, dasabuvir, doxorubicin, ledipasvir, paritaprevir, prednisone, ribavirin, ritonavir, rituximab, sofosbuvir, vincristine, adult, Article, chronic hepatitis, clinical article, clinical outcome, cohort analysis, diffuse large B cell lymphoma, drug tolerance, female, follow up, genotype, hepatitis C, human, liver toxicity, male, middle aged, multicenter study, overall survival, priority journal, progression free survival, retrospective study, sustained virologic response, treatment response",
author = "M. Merli and M. Frigeni and L. Alric and C. Visco and C. Besson and L. Mannelli and {Di Rocco}, A. and A. Ferrari and L. Farina and M. Pirisi and F. Piazza and V. Loustaud-Ratti and A. Arcari and D. Marino and A. Sica and M. Goldaniga and C. Rusconi and M. Gentile and E. Cencini and F. Benanti and M.G. Rumi and V.V. Ferretti and P. Grossi and M. Gotti and R. Sciarra and M.C. Tisi and I. Cano and V. Zuccaro and F. Passamonti and L. Arcaini",
note = "Export Date: 11 February 2020 CODEN: OCOLF Correspondence Address: Merli, M.; Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi–ASST Sette Laghi, University of InsubriaItaly; email: michele.merli@asst-settelaghi.it",
year = "2019",
doi = "10.1634/theoncologist.2018-0331",
language = "English",
volume = "24",
pages = "e720--e729",
journal = "Oncologist",
issn = "1083-7159",
publisher = "Wiley Blackwell",
number = "8",
}